[1] WHO, Global Tuberculosis Report 2018, 2018, http://www.who.int/tb/publications/global_report/en/.
[2] Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis. 2017;64(2):111-115. doi:10.1093/cid/ciw778.
[3] Chan ED, Heifets L, Iseman MD. Immunologic diagnosis of tuberculosis: a review. Tuber Lung Dis. 2000;80(3):131-40
[4] Baghaei P, Tabarsi P, Sabour H, et al. Detection of Antibodies Against 6, 16 and 38 kDa Antigens of Mycobacterium tuberculosis as a Rapid Test for Diagnosis of Tuberculosis. Tanaffos. 2011;10(4):17-22.
[5] Anochie PI, Onyeneke EC, Ogu AC, et al. Recent advances in the diagnosis of Mycobacterium tuberculosis. Germs. 2012;2(3):110-120. doi:10.11599/germs.2012.1021.
[6] Feng X, Yang X, Xiu B, et al. IgG, IgM and IgA antibodies against the novel polyprotein in active tuberculosis. BMC Infectious Diseases. 2014;14: 336. doi:10.1186/1471-2334-14-336.
[7] Sampson SL. Mycobacterial PE/PPE Proteins at the Host-Pathogen Interface. Clinical and Developmental Immunology. 2011; 2011:497203. doi:10.1155/2011/497203.
[8] Li Y, Miltner E, Wu M, et al. A Mycobacterium avium PPE gene is associated with the ability of the bacterium to grow in macrophages and virulence in mice. Cell Microbiol. 2005 Apr;7(4):539-48.
[9] Chakhaiyar P, Nagalakshmi Y, Aruna B et al. Regions of high antigenicity within the hypothetical PPE major polymorphic tandem repeat open-reading frame, Rv2608, show a differential humoral response and a low T cell response in various categories of patients with tuberculosis. J Infect Dis. 2004 Oct 1;190(7):1237-44.
[10] Khan N, Alam K, Nair S, Valluri VL, Murthy KJR, Mukhopadhyay S. Association of Strong Immune Responses to PPE Protein Rv1168c with Active Tuberculosis. Clinical and Vaccine Immunology: CVI. 2008;15(6):974-980. doi:10.1128/CVI.00485-07.
[11] Singh KK, Dong Y, Patibandla SA, McMurray DN, Arora VK, Laal S. Immunogenicity of the Mycobacterium tuberculosis PPE55 (Rv3347c) Protein during Incipient and Clinical Tuberculosis. Infection and Immunity. 2005;73(8):5004-5014. doi:10.1128/IAI.73.8.5004-5014.2005.
[12] Chen J, Su X, Zhang Y et al. Novel recombinant RD2- and RD11-encoded Mycobacterium tuberculosis antigens are potential candidates for diagnosis of tuberculosis infections in BCG-vaccinated individuals. Microbes Infect. 2009 Sep;11(10-11):876-85. doi: 10.1016/j.micinf.2009.05.008
[13] Parkash O, Singh BP, Pai M. Regions of differences encoded antigens as targets for immunodiagnosis of tuberculosis in humans. Scand J Immunol. 2009 Oct;70(4):345-57. doi: 10.1111/j.1365-3083.2009.02312.x.
[14] Al-Attiyah R, Mustafa AS. Characterization of Human Cellular Immune Responses to Novel Mycobacterium tuberculosis Antigens Encoded by Genomic Regions Absent in Mycobacterium bovis BCG. Infection and Immunity. 2008;76(9):4190-4198. doi:10.1128/IAI.00199-08.
[15] Sardella IG, Mulinari ACP, Fonseca LS et al. Cloning, Expression and Characterization of Fusion Proteins Based on Peptides of Rv1980c Disrupting Rv3019c Sequence and Evaluation of its Potential Immunoreactivity in Pulmonary Tuberculosis Sera. Mycobact Dis 2015. 5:183. doi: 10.4172/2161-1068.1000183
[16] Silva VM, Sardella IG, Luiz RR et al. Immunoreactivity of five antigens of Mycobacterium tuberculosis in patients attending a public health care facility in an area with high endemicity for TB. Microbiol Immunol. 2008 Nov;52(11):544-50. doi: 10.1111/j.1348-0421.2008.00072.x.
[17] American Thoracic Society. (2000) Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 161: 1376–95.
[18] Mustafa AS, Al-Saidi F, El-Shamy AS et al. Cytokines in response to proteins predicted in genomic regions of difference of Mycobacterium tuberculosis. Microbiol Immunol. 2011 Apr;55(4):267-78. doi: 10.1111/j.1348-0421.2011.00307.x.
[19] Kim SY, Park MS, Kim YS et al. The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals and controls with the TB antigens ESAT-6, CFP-10 and TB7.7. Scand J Immunol. 2012 Dec;76(6):580-6. doi: 10.1111/j.1365-3083.2012.02776.x.
[20] Losi M, Knights AJ, Mariani F et al. QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens. Eur Respir J. 2016 Feb;47(2):660-4. doi: 10.1183/13993003.01015-2015.
[21] Tortora GJ, Funke BR, Case CL 2012. Microbiologia. Doenças Microbianas do trato respiratório. Arthmed. Brasil. 674-704pp.
[22] Karboul A, Mazza A, Gey van Pittius NC, Ho JL, Brousseau R, Mardassi H. Frequent Homologous Recombination Events in Mycobacterium tuberculosis PE/PPE Multigene Families: Potential Role in Antigenic Variability. Journal of Bacteriology. 2008;190(23):7838-7846. doi:10.1128/JB.00827-08.
[23] Akhter Y, Ehebauer MT, Mukhopadhyay S et al. The PE/PPE multigene family codes for virulence factors and is a possible source of mycobacterial antigenic variation: perhaps more? Biochimie. 2012 Jan;94(1):110-6. doi: 10.1016/j.biochi.2011.09.026.
[24] McEvoy CRE, Cloete R, Müller B, et al. Comparative Analysis of Mycobacterium tuberculosis pe and ppe Genes Reveals High Sequence Variation and an Apparent Absence of Selective Constraints. Neyrolles O, ed. PLoS ONE. 2012;7(4): e30593. doi: 10.1371/journal.pone.0030593.
[25] Vordermeier HM, Hewinson RG, Wilkinson RJ, et al. Conserved Immune Recognition Hierarchy of Mycobacterial PE/PPE Proteins during Infection in Natural Hosts. Sechi LA, ed. PLoS ONE. 2012;7(8): e40890. doi: 10.1371/journal.pone.0040890.
[26] Broger T, Basu Roy R, Filomena A, et al. Diagnostic Performance of Tuberculosis-Specific IgG Antibody Profiles in Patients with Presumptive Tuberculosis from Two Continents. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2017;64(7):947-955. doi:10.1093/cid/cix023.
[27] Gutlapalli R, Sykam A, Tenali SP, Chandran P, Suneetha S, Suneetha LM. Detection of Tuberculosis in HIV Co-infected Individuals: Use of Multiple ELISA Responses to 38kDa, Lipoarabinomannan and ESAT– 6 of M. tuberculosis. Journal of Clinical and Diagnostic Research: JCDR. 2016;10(2): KC01-KC04. doi:10.7860/JCDR/2016/16559.7322.
[28] Liaquat A, Iram S, Hussain S, Yusuf NW, Azeem H. Concomitant presence of culture-proven active pulmonary tuberculosis in patients with chronic obstructive pulmonary disease - A hospital-based study. Pakistan Journal of Medical Sciences. 2015;31(6):1344-1348. doi:10.12669/pjms.316.8166.
[29] Zhang H, Wang J, Lei J et al. PPE protein (Rv3425) from DNA segment RD11 of Mycobacterium tuberculosis: a potential B-cell antigen used for serological diagnosis to distinguish vaccinated controls from tuberculosis patients. 2007 Feb;13(2):139-45.
[30] Abebe F, Belay M, Legesse M, K. L. M. C. F, Ottenhoff THM. IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals. Neyrolles O, ed. PLoS ONE. 2018;13(1): e0190989. doi: 10.1371/journal.pone.0190989.
[31] Niki M, Suzukawa M, Shunsuke A. et al. Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development. Journal of Immunology Research. Volume 2015, Article ID 527395, 13 pages. http://dx.doi.org/10.1155/2015/527395
[32] Williams A, Reljic R, Naylor I, et al. Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs. Immunology. 2004;111(3):328-33.
[33] Kunnath-Velayudhan S, Salamon H, Wang H-Y, et al. Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(33):14703-14708. doi:10.1073/pnas.1009080107.
[34] Louw JS, Mabaso M, Peltzer K 2016. Change in Health-Related Quality of Life among Pulmonary Tuberculosis Patients at Primary Health Care Settings in South Africa: A Prospective Cohort Study. PLoS One 11: e0151892.
[35] Mertens JR, Flisher AJ, Ward CL, Bresick GF, Sterling SA, Weisner CM. Medical Conditions of Hazardous Drinkers and Drug Users in Primary Care Clinics in Cape Town, South Africa. J Drug Issues. 2009;39(4):75796776.
[36] Chin ST, Ignatius J, Suraiya S, Tye GJ, Sarmiento ME, Acosta A, Norazmi MN, Lim TS 2015. Comparative study of IgA V H 3 gene usage in healthy TST − and TST + population exposed to tuberculosis: deep sequencing analysis. Immunology 144: 302–311.
[37] Achkar JM, Casadevall A. Antibody-Mediated Immunity against Tuberculosis: Implications for Vaccine Development. Cell host & microbe. 2013;13(3):250-262. doi: 10.1016/j.chom.2013.02.009.
[38] Xiao J, Xiong Y, Chen Y, et al. Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection. Frontiers in Cellular and Infection Microbiology. 2017; 7:495. doi:10.3389/fcimb.2017.0049